Vaborbactam is a novel β-lactamase inhibitor that is combined with the carbapenem antibiotic meropenem to enhance its efficacy against certain multidrug-resistant bacterial infections. It specifically inhibits class A and class C β-lactamases, which are enzymes produced by bacteria to confer resistance to β-lactam antibiotics.
